tiprankstipranks
Takeda Pharmaceutical Co Ltd (TKPHF)
OTHER OTC:TKPHF
US Market
TKPHF
Takeda Pharmaceutical Co
RESEARCH TOOLSreports
Want to see TKPHF full AI Analyst Report?

Takeda Pharmaceutical Co (TKPHF) Financial Statements

35 Followers

Takeda Pharmaceutical Co Financial Overview

Takeda Pharmaceutical Co's market cap is currently $53.18B. The company's EPS TTM is $0.41850084; its P/E ratio is 18.42; and it has a dividend yield of 4.28%. Takeda Pharmaceutical Co is scheduled to report earnings on January 28, 2026, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 4.58T¥ 4.26T¥ 4.03T¥ 3.57T¥ 3.20T
Gross Profit¥ 2.46T¥ 2.32T¥ 2.30T¥ 2.04T¥ 1.80T
Operating Income¥ 627.54B¥ 531.42B¥ 658.29B¥ 610.50B¥ 447.61B
EBITDA¥ 1.13T¥ 927.95B¥ 1.18T¥ 1.04T¥ 1.07T
Net Income¥ 107.93B¥ 144.07B¥ 317.02B¥ 230.06B¥ 376.00B
Balance Sheet
Cash & Short-Term Investments¥ 385.11B¥ 457.80B¥ 533.53B¥ 849.70B¥ 966.22B
Total Assets¥ 14.25T¥ 15.11T¥ 13.96T¥ 13.18T¥ 12.91T
Total Debt¥ 5.09T¥ 5.46T¥ 4.86T¥ 4.81T¥ 5.07T
Net Debt¥ 4.85T¥ 5.26T¥ 4.63T¥ 3.96T¥ 4.11T
Total Liabilities¥ 7.31T¥ 7.83T¥ 7.60T¥ 7.49T¥ 7.74T
Stockholders' Equity¥ 6.94T¥ 7.27T¥ 6.35T¥ 5.68T¥ 5.17T
Cash Flow
Free Cash Flow¥ 761.70B¥ 464.90B¥ 736.56B¥ 897.97B¥ 793.87B
Operating Cash Flow¥ 962.49B¥ 640.32B¥ 877.22B¥ 1.02T¥ 905.07B
Investing Cash Flow¥ -385.36B¥ -488.21B¥ -615.72B¥ -204.44B¥ 392.04B
Financing Cash Flow¥ -638.44B¥ -254.04B¥ -600.59B¥ -962.06B¥ -981.00B
Currency in JPY

Takeda Pharmaceutical Co Earnings and Revenue History

Income Statement >

Takeda Pharmaceutical Co Debt to Assets

Balance Sheet >

Takeda Pharmaceutical Co Cash Flow

Cash Flow >

Takeda Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >